Professor Graeme Milligan and Professor Andrew Tobin have worked together for more than 10 years to establish ‘Translational Pharmacology’ as a theme of excellence at University of Glasgow. They have cultivated extensive and highly productive links with both early-stage and major international biopharmaceutical companies. Building on the insights gained, they have developed their research interests … Read more

A University of Glasgow spinout company has received a substantial multi-million Euro award from the European Union (EU) Malaria Fund, to extend their world-leading malaria research into a drug that will hopefully, one day, cure malaria and prevent the disease from spreading. The newly-established Keltic Pharma Therapeutics Ltd – co-founded by Professor Andrew Tobin, Professor … Read more